STOCK TITAN
  1. Home
  2. Sec-filings
  3. ABBV
  4. [ARS] AbbVie Inc. SEC Filing

[ARS] AbbVie Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
ARS

Rhea-AI Filing Summary

Analyzing...
ARS - AbbVie Inc.

ARS Filing - AbbVie Inc.

This filing is available as a PDF document.

Filing Type: ARS

Company: AbbVie Inc. (ABBV)

Acceptance Date: 2026-03-23T17:09:41.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Abbvie Inc

NYSE:ABBV

View ABBV Stock Overview →

ABBV Rankings

#27 Ranked by Market Cap
#780 Ranked by Dividends
#1004 52-Week Gainer
#1377 YTD Gainer
#1442 Monthly Gainer
#1027 Ranked by Short %Change

ABBV Latest News

Mar 26, 2026
Allergan Aesthetics Reinforces Scientific Differentiation and Leadership with 21 Evidence-Based E-Posters at the 2026 Aesthetic & Anti-Aging Medicine World Congress (AMWC)
Mar 26, 2026
Allergan Aesthetics Ushers in a New Age of Hyaluronic Acid (HA) Injectables with JUVÉDERM® at AMWC Monaco
Mar 24, 2026
NImmune Biopharma to Present Novel Mechanistic, Efficacy and Translational Data on LANCL2-Targeting Therapeutics Supporting Significant Pipeline-in-a-Drug Potential at IMMUNOLOGY2026
Mar 24, 2026
AbbVie Named Official Pharmaceutical Partner of Major League Baseball
Mar 19, 2026
Allergan Aesthetics Reveals Evolution in Approach to Modern Aesthetic Treatments with Comprehensive Global Survey and New Educational Solutions

ABBV Latest SEC Filings

Mar 26, 2026
[SCHEDULE 13G/A] AbbVie Inc. Amended Passive Investment Disclosure
Mar 23, 2026
[DEF 14A] AbbVie Inc. Definitive Proxy Statement
Mar 11, 2026
[Form 4/A] AbbVie Inc. Amended Insider Trading Activity
Mar 9, 2026
[PRE 14A] AbbVie Inc. Preliminary Proxy Statement
Mar 6, 2026
[Form 4] AbbVie Inc. Insider Trading Activity

ABBV Stock Data

362.83B
1.77B
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States
NORTH CHICAGO